Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of MRI in Detection of Breast Cancer Molecular Subtypes in Correlation With Immunohistochemistry Results

NCT06707584 is registered in ClinicalTrials.gov with Lamiaa Gomaa Ahmed Elsayed as lead sponsor.

NCT NCT06707584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06707584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of MRI in Detection of Breast Cancer Molecular Subtypes in Correlation With Immunohistochemistry Results
Lead sponsor
Lamiaa Gomaa Ahmed Elsayed
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2025
Completion date
December 1, 2030
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mri in breast cancer